Amy E. Tapper - 12 Aug 2022 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Amy Tapper
Issuer symbol
IMGO
Transactions as of
12 Aug 2022
Transactions value $
-$204,100
Form type
4
Filing time
16 Aug 2022, 16:06:59 UTC
Previous filing
21 Jul 2022
Next filing
04 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Options Exercise $1.89K +750 +0.63% $2.52* 120K 12 Aug 2022 Direct F1
transaction IMGO Common Stock Sale -$13.4K -750 -0.63% $17.90 119K 12 Aug 2022 Direct F1
transaction IMGO Common Stock Options Exercise $29K +11.5K +9.66% $2.52* 131K 15 Aug 2022 Direct F1
transaction IMGO Common Stock Sale -$222K -11.5K -8.81% $19.26 119K 15 Aug 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -750 -1.15% $0.00 64.2K 12 Aug 2022 Common Stock 750 $2.52 Direct F1
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -11.5K -17.7% $0.00 53.5K 15 Aug 2022 Common Stock 11.5K $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $19.20 to $19.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Remarks:

Chief, Technical Operations